Detalles de la búsqueda
1.
Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
Subst Use Misuse
; 55(14): 2438-2442, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957797
2.
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.
Subst Use Misuse
; 53(2): 220-229, 2018 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29257919
3.
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences.
Gene Protein Dis
; 3(1)2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38766604
4.
Psychostimulants for Children: Are We Over or Under Dosing?
J Addict Psychiatry
; 7(1): 1-4, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560458
5.
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
J Neurol Sci
; 453: 120809, 2023 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774561
6.
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.
Int J Environ Res Public Health
; 19(1)2022 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35010811
7.
Why haven't we solved the addiction crisis?
J Neurol Sci
; 442: 120404, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36084363
8.
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
J Pers Med
; 12(2)2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35207809
9.
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
Psychol Res Behav Manag
; 14: 2115-2134, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949945
10.
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
J Pers Med
; 11(3)2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809702
11.
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling.
Curr Psychopharmacol
; 102021 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34707968
12.
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic.
Curr Psychopharmacol
; 10(2): 86-97, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34466374
13.
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development.
Curr Psychopharmacol
; 102021 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34707969
14.
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
Mol Neurobiol
; 58(7): 3335-3346, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33683627
15.
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
Curr Psychopharmacol
; 9(3): 164-184, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-37361136
16.
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Curr Psychopharmacol
; 9(1): 7-21, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32432025
17.
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
Curr Pharm Biotechnol
; 21(6): 528-541, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820688
18.
The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population.
J Syst Integr Neurosci
; 42018 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31660252
19.
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.
Biomed J Sci Tech Res
; 2(2): 1-4, 2018 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370423
20.
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.
EC Psychol Psychiatr
; 7(8): 564-579, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30417173